112 related articles for article (PubMed ID: 17918045)
1. Quality management of nuchal translucency measurement in residents.
Frey Tirri B; Troeger C; Holzgreve W; Tercanli S
Ultraschall Med; 2007 Oct; 28(5):484-8. PubMed ID: 17918045
[TBL] [Abstract][Full Text] [Related]
2. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
3. Impact of nuchal cord on measurement of fetal nuchal translucency thickness.
Scheier M; Egle D; Himmel I; Ramoni A; Viertl S; Huter O; Marth C
Ultrasound Obstet Gynecol; 2007 Aug; 30(2):197-200. PubMed ID: 17573675
[TBL] [Abstract][Full Text] [Related]
4. Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening.
Sahota DS; Leung WC; To WK; Chan WP; Lau TK; Leung TY
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1039-43. PubMed ID: 21854135
[TBL] [Abstract][Full Text] [Related]
5. Fetal nuchal translucency scan in Nigeria.
Oloyede OA; Abbey M; Oloyede AA; Nwachukwu O
Pan Afr Med J; 2014; 18():62. PubMed ID: 26113896
[TBL] [Abstract][Full Text] [Related]
6. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening.
Weingertner AS; Kohler M; Firtion C; Vayssière C; Favre R
Fetal Diagn Ther; 2006; 21(5):433-8. PubMed ID: 16912493
[TBL] [Abstract][Full Text] [Related]
7. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
8. Nuchal Translucency Quality Review (NTQR) program: first one and half million results.
Cuckle H; Platt LD; Thornburg LL; Bromley B; Fuchs K; Abuhamad A; Benacerraf B; Copel JA; Depp R; D'Alton M; Goldberg J; O'Keeffe D; Spitz J; Toland G; Wapner R;
Ultrasound Obstet Gynecol; 2015 Feb; 45(2):199-204. PubMed ID: 24753079
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
10. Nuchal translucency and first trimester risk assessment: a systematic review.
Sheppard C; Platt LD
Ultrasound Q; 2007 Jun; 23(2):107-16. PubMed ID: 17538486
[TBL] [Abstract][Full Text] [Related]
11. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis.
Koster MP; Wortelboer EJ; Engels MA; Stoutenbeek PH; Elvers LH; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2009 Aug; 34(2):136-41. PubMed ID: 19562664
[TBL] [Abstract][Full Text] [Related]
12. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
13. Learning curve in measurement of fetal frontomaxillary facial angle at 11-13 weeks of gestation.
Yang X; Chen M; Wang HF; Leung TY; Borenstein M; Nicolaides K; Sahota DS; Lau TK
Ultrasound Obstet Gynecol; 2010 May; 35(5):530-4. PubMed ID: 20127748
[TBL] [Abstract][Full Text] [Related]
14. How imprecise may the measurement of fetal nuchal translucency be without worsening first-trimester screening?
Schmidt P; Staboulidou I; Elsässer M; Vaske B; Hillemanns P; Scharf A
Fetal Diagn Ther; 2008; 24(3):291-5. PubMed ID: 18818502
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome in fetuses with increased nuchal translucency.
Dane B; Dane C; Cetin A; Kiray M; Sivri D; Yayla M
J Perinatol; 2008 Jun; 28(6):400-4. PubMed ID: 18337744
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
17. Comparison of first-trimester contingent screening strategies for Down syndrome.
Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chen M; Lau TK
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
[TBL] [Abstract][Full Text] [Related]
19. Impact of a shift in nuchal translucency measurements on the detection rate of first-trimester Down syndrome screening: A population-based study.
Fries N; Salomon LJ; Muller F; Dreux S; Houfflin-Debarge V; Coquel P; Kleinfinger P; Dommergues M;
Prenat Diagn; 2018 Jan; 38(2):106-109. PubMed ID: 29231978
[TBL] [Abstract][Full Text] [Related]
20. [A simple self-assessment tool for the first-trimester ultrasound images].
Dhombres F; Friszer S; Bessis R; Jouannic JM
Gynecol Obstet Fertil; 2015 Dec; 43(12):761-6. PubMed ID: 26476892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
